Lilly’s pipeline drug retatrutide sets new threshold for weight loss at medical meeting reveal
Eli Lilly’s experimental weight loss drug appears to have set a new bar, helping obese patients in a Phase II study lose 24% of their …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
